Testicular cancer is a malignancy that occurs in the testes, the male reproductive glands responsible for producing sperm and hormones. It is one of the most common cancers in young men, typically affecting individuals between the ages of 15 and 34. Although it accounts for a small percentage of all male cancers, it has a high cure rate when detected early, and treatments may include surgery, chemotherapy, and radiation therapy depending on the stage and type of cancer.

Several risk factors are associated with an increased likelihood of developing testicular cancer, including a family history of the disease, cryptorchidism (undescended testicle), and specific genetic predispositions such as Klinefelter syndrome. Additionally, having a history of testicular cancer in one testis raises the risk of developing cancer in the other. Environmental factors, including exposure to certain chemicals and conditions affecting hormonal levels during fetal development, may also contribute to risk.

Common symptoms of testicular cancer include a noticeable lump or swelling in either testis, which may be painless or associated with discomfort. Other symptoms can include a feeling of heaviness in the scrotum, dull ache in the lower abdomen or groin, and changes in the size or shape of the testes. If the cancer has spread, additional symptoms such as back pain, shortness of breath, or abdominal discomfort may occur.

Testicular cancer primarily originates from germ cells, responsible for sperm production. Although the exact cause remains unknown, several risk factors have been identified, including undescended testicles, genetic predispositions (such as a family history of testicular cancer), and certain conditions such as Klinefelter syndrome. Environmental factors and exposure to specific chemicals may also increase the risk of developing this type of cancer.

Diagnosis of testicular cancer typically begins with a physical examination, followed by imaging studies such as scrotal ultrasound to identify abnormal masses. Blood tests measuring tumor markers, including alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH), can aid in diagnosing and monitoring the disease. A definitive diagnosis usually requires a surgical procedure called orchiectomy, where the affected testicle is removed and examined histologically.

The primary treatment for testicular cancer involves surgical removal of the affected testicle, known as radical inguinal orchiectomy. Depending on the stage and type of cancer, additional treatments may include surveillance, chemotherapy, or radiation therapy. A multidisciplinary approach is often critical, as oncologists, urologists, and radiation specialists collaborate to formulate a personalized treatment plan tailored to the patient's specific needs.

While there are no guaranteed methods to prevent testicular cancer, several strategies may help reduce risk. Regular self-examinations of the testicles can facilitate early detection of abnormalities, enabling prompt medical evaluation. Additionally, maintaining a healthy lifestyle, which includes avoiding exposure to environmental toxins and managing hormonal imbalances, may contribute to overall reproductive health.